In an interview with STAT+, Zack Lipton, chief technology officer of Abridge, talks about the development of the market for AI note transcribing tools. Abridge is rebranding itself as more than just an AI scribe and is discussing partnerships with Epic and Microsoft. Abridge has raised more than $700 million in investments at a $5 billion valuation and is used by nearly 200 health systems. Epic, which controls 42% of the acute hospital EHR market, has announced AI Charting, an active Microsoft-powered note-taking, ordering and diagnosis tool that could disrupt the ambient scribe market. Abridge has deep integration with Epic, including co-development of features, but Epic has ended the program under which it acquired a stake in Abridge. Abridge CEO Shiv Rao assured customers that integrations with Epic are 100% reliable. Lipton emphasizes the transition to complex workflows in emergency and inpatient departments.[1][5][6][3][4][7]